This study is testing a device called the PMT/Blackrock Combination Device. This device uses electrodes placed directly on the surface of the brain (electrocorticography or ECoG) to record brain activity. Researchers want to see if these brain signals can help people with severe neurological conditions control complex robotic systems and produce speech. You might be able to join if you are over 21 and have limited use of your upper limbs due to conditions like ALS, spinal cord injury, stroke, multiple sclerosis, or muscular dystrophies. The study will look at how safe the device is and how well it works over a period of up to six years after it's implanted. The current status of this study is unclear.

Study design

This interventional study plans to enroll 3 participants. It is not specified if it is randomized or blinded.

What's involved

Participants will have electrodes implanted on their brain and will undergo training and assessment to control a robotic system and produce speech.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for up to 6 years after the device is implanted.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.